|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.950 CAD | +2.43% |
|
0.00% | -23.38% |
| 06-15 | XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange | MT |
| 06-15 | Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update | MT |
| Market Cap | 3.63M 2.58M 2.26M 2.1M 1.93M 249M 3.69M 24.99M 9.78M 122M 9.68M 9.47M 421M | P/E 2024 |
-1.02x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8M 1.99M 1.74M 1.62M 1.49M 192M 2.85M 19.3M 7.55M 94.03M 7.48M 7.31M 325M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
91.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.43% | ||
| Current month | -7.81% | ||
| 1 month | -2.64% | ||
| 3 months | -24.36% | ||
| 6 months | -23.38% | ||
| Current year | -23.38% |
| 1 month | 2.88 |  | 3.2 |
| Current year | 2.42 | | 4.83 |
| 1 year | 2.42 | | 9.85 |
| 3 years | 2.42 | | 49.95 |
| 5 years | 2.42 | | 449.05 |
| 10 years | 2.42 | | 449.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 2026-06-14 |
Allen Davidoff
CEO | Chief Executive Officer | 66 | 2018-01-08 |
Michael Bumby
DFI | Director of Finance/CFO | 62 | 2024-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Davidoff
BRD | Director/Board Member | 66 | 2018-01-08 |
| Chairman | 69 | 2022-06-02 | |
George Scorsis
BRD | Director/Board Member | 50 | 2026-03-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/2/26 | Option | Director | 20,000 | 0.2873% | ||
| 2/2/26 | Other | Director | 0 | 0% | ||
| 1/7/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.43% | 0.00% | -55.97% | -92.87% | 3.62M | |
| -0.43% | -1.26% | +52.13% | +85.69% | 55.57B | |
| -0.24% | +1.04% | +55.76% | +54.21% | 54.26B | |
| -0.54% | -0.17% | -17.60% | -15.43% | 23.35B | |
| -1.82% | -2.89% | +3.61% | +405.88% | 23.54B | |
| +0.05% | +1.68% | +38.71% | -4.57% | 20.32B | |
| +3.16% | +2.74% | +37.33% | -31.36% | 17.36B | |
| +1.08% | +3.77% | +36.92% | +593.96% | 15.59B | |
| +0.43% | -1.67% | +166.53% | +299.61% | 14.96B | |
| -2.03% | -1.03% | +23.63% | +179.23% | 14.11B | |
| Average | +0.21% | -0.20% | +34.11% | +147.43% | 23.91B | |
| Weighted average by Cap. | -0.18% | -0.23% | +43.63% | +136.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.31M -2.35M -2.06M -1.91M -1.76M -227M -3.36M -22.8M -8.92M -111M -8.83M -8.64M -384M | -2.66M -1.89M -1.65M -1.53M -1.41M -182M -2.7M -18.28M -7.15M -89.05M -7.08M -6.93M -308M |
| Net Debt | -2.43M -1.73M -1.51M -1.41M -1.29M -167M -2.47M -16.75M -6.56M -81.62M -6.49M -6.35M -282M | -827K -587K -515K -478K -439K -56.67M -839K -5.69M -2.23M -27.73M -2.2M -2.16M -95.8M |
Employees
-
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- XRTX Stock
Select your edition
All financial news and data tailored to specific country editions
